Search Login Register
Eflornithine
(Ornidyl)
Summary
Description:
An inhibitor of ornithine decarboxylase, the rate limiting enzyme of the polyamine biosynthetic pathway.
Also Known As:
Ornidyl; Vaniqa; Difluoromethylornithine; DL-alpha-Difluoromethylornithine; Eflornithine Hydrochloride Show All >>
Networked: 718
relevant articles (43 outcomes,
96 trials/studies)
for this Drug
Key Diseases for which Eflornithine is
Relevant
-
Neoplasms (Cancer)
:
8 outcomes 18 studies in 188 results
-
African Trypanosomiasis (Nagana)
:
7 outcomes 6 studies in 52 results
-
Trypanosomiasis
:
4 outcomes 4 studies in 37 results
-
Adenocarcinoma
:
3 outcomes 5 studies in 24 results
-
Infection
:
3 outcomes 1 study in 33 results
Show All >>
Drugs Related to Eflornithine
-
Ornithine Decarboxylase (Decarboxylase, Ornithine)
-
Eflornithine (Ornidyl)
-
Nifurtimox
-
Mitoguazone (MGBG)
-
Piroxicam (Feldene)
-
Aspirin (Acetylsalicylic Acid)
-
Bleomycin (Blenoxane)
-
Suramin (Suramin Sodium)
-
melarsen oxide
-
Putrescine
Show All >>
Therapies Related to Eflornithine
-
Oral Administration
-
Heterologous Transplantation (Xenotransplantation)
-
Chemoprevention
-
Drug Therapy (Chemotherapy)
-
Lasers (Laser)
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.